Effect of type I interferons on the expression of feline leukaemia virus

Veterinary Microbiology

Volumn 123, Issue 1-3, 2007, Pages 180-186

  Collado, Victorio M ^a   Gómez Lucía, Esperanza ^a   Tejerizo, Germán ^a   Miró, Guadalupe ^a   Escolar, Elena ^a   Martín, Sonsoles ^a   Doménech, Ana ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Feline leukaemia virus; FeLV; Interferon (IFN); p27; RT; Treatment; Viability

Indexed keywords

INTERFERON; LIPOCORTIN 5; RECOMBINANT ALPHA2A INTERFERON; RNA DIRECTED DNA POLYMERASE; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; FELINE LEUKEMIA VIRUS; IC 50; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; VIRUS EXPRESSION;

ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; CATS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INTERFERON TYPE I, RECOMBINANT; LEUKEMIA VIRUS, FELINE; RNA-DIRECTED DNA POLYMERASE;

FELIDAE;

EID: 34250173801     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2007.03.008     Document Type: Article

References (25)

1. Aboud M., Kimchi R., Bakhanashvili M., and Salzberg S. Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon. J. Virol. 40 (1981) 830-838
2. Agy M.B., Acker R.L., Sherbert C.H., and Katze M.G. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins. Virology 214 (1995) 379-386
3. Baldwin S.L., Powell T.D., Sellins K.S., Radecki S.V., John Cohen J., and Milhausen M.J. The biological effects of five feline IFN-alpha subtypes. Vet. Immunol. Immunopathol. 99 (2004) 153-167
4. Balkwill F.R. Interferons. Lancet 13 (1989) 1060-1063
5. Belardelli F., Ferrantini M., Proietti E., and Kirkwood J.M. Interferon-alpha in tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 13 (2002) 119-134
6. de Mari K., Maynard L., Sanquer A., Lebreux B., and Eun H.M. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J. Vet. Intern. Med. 18 (2004) 477-482
7. Ekstrand D.H., Awad R.J., Kallander C.F., and Gronowitz J.S. A sensitive assay for the quantification of reverse transcriptase activity based on the use of carrier-bound template and non-radioactive-product detection, with special reference to human-immunodeficiency-virus isolation. Biotechnol. Appl. Biochem. 23 (1996) 95-105
8. Feng X., Heyden N.V., and Ratner L. Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J. Virol. 77 (2003) 13389-13395
9. Gerlach N., Schimmer S., Weiss S., Kalinke U., and Dittmer U. Effects of type I interferons on Friend retrovirus infection. J. Virol. 80 (2006) 3438-3444
10. Hartmann K. Feline leukaemia virus infection. In: Greene C.E. (Ed). Infectious Diseases of the Dog and Cat. 3rd ed. (2006), Saunders Elsevier, St. Louis 105-131
11. Hoover E.A., Zeidner N.S., and Mullins J.I. Therapy of presymptomatic FeLV-induced immunodeficiency syndrome with AZT in combination with alpha interferon. Ann. N.Y. Acad. Sci. 616 (1990) 258-269
12. Jarrett O. Strategies of retrovirus survival in the cat. Vet. Microbiol. 69 (1999) 99-107
13. Juste R.A., Ott T.L., Kwang J., Bazer F.W., and de la Concha-Bermejillo A. Effects of recombinant interferon-tau on ovine lentivirus replication. J. Interferon Cytokine Res. 16 (1996) 989-994
14. Kiermer V., Van Lint C., Briclet D., Vanhulle C., Kettmann R., Verdin E., Burny A., and Droogmans L. An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression. J. Virol. 72 (1998) 5526-5534
15. Niermann G.L., and Buehring G.C. Hormone regulation of bovine leukemia virus via de long terminal repeat. Virology 239 (1997) 249-258
16. Pedretti E., Passeri B., Amadori M., Isola P., Di Pede P., Telera A., Vescovini R., Quintavalla F., and Pistillo M. Low-dose interferon-alpha treatment for feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 109 (2006) 245-254
17. Pestka S., Krause C.D., and Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202 (2004) 8-32
18. Riondato F., Gianella P., Guglielmino R., Cagnasso A., and Bo S. Effects of interferon alpha (INF-alpha) therapy on peripheral blood lymphocyte subsets from FIV and FeLV naturally infected cats. Vet. Res. Commun. 27 (2003) 429-432
19. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
20. Shirazi Y., and Pitha P.M. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J. Virol. 66 (1992) 1321-1328
21. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
22. Tejerizo G., Domenech A., Illera J.C., Collado V.M., and Gomez-Lucia E. Effect of 17beta-estradiol and progesterone on the expression of FeLV in chronically infected cells. Vet. Microbiol. 109 (2005) 191-199
23. Tizard I.R. Veterinary Immunology: An Introduction (2004), Saunders, Philadelphia pp. 428-440
24. Williams B.R. Signal transduction and transcriptional regulation of interferon-alpha-stimulated genes. J. Interferon Res. 11 (1991) 207-213
25. Zeidner N.S., Myles M.H., Mathiason-DuBard C.K., Dreitz M.J., Mullins J.I., and Hoover E.A. Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome. Antimicrob. Agents Chemother. 34 (1990) 1749-1756